Products Categories
CAS No.: | 56-10-0 |
---|---|
Name: | 2-(2-Aminoethyl)isothiourea dihydrobromide |
Article Data: | 2 |
Molecular Structure: | |
Formula: | C3H9N3S.2HBr |
Molecular Weight: | 281.014 |
Synonyms: | Carbamimidothioicacid, 2-aminoethyl ester, dihydrobromide (9CI);Pseudourea, 2-(2-aminoethyl)-2-thio-,dihydrobromide (8CI);2-(2-Aminoethyl)-2-thiopseudourea dihydrobromide;2-(2-Aminoethyl)-2-thiopseudourea hydrobromide;2-(b-Aminoethyl)isothiuronium bromide hydrobromide;AET;Antiradon;Ixecur;NSC 22877;S-(2-Aminoethyl)isothiuronium bromidehydrobromide;S-(b-Aminoethyl)isothiuroniumbromide hydrobromide;Surrectan; |
EINECS: | 200-257-0 |
Density: | 1.94 g/cm3 |
Melting Point: | 190-196 °C(lit.) |
Boiling Point: | 231.1 °C at 760 mmHg |
Flash Point: | 93.6 °C |
Solubility: | almost transparency |
Hazard Symbols: | Xn |
Risk Codes: | 22-36/37/38 |
Safety: | 26-36/37-22 |
PSA: | 101.19000 |
LogP: | 2.98830 |
What can I do for you?
Get Best Price
Product Name: Antiradon (CAS NO.56-10-0)
Molecular Formula: C3H11Br2N3S
Molecular Weight: 281.01g/mol
Mol File: 56-10-0.mol
Einecs: 200-257-0
Melting Point: 190-196 °C(lit.)
Boiling point: 231.1 °C at 760 mmHg
Flash Point: 93.6 °C
Enthalpy of Vaporization: 46.78 kJ/mol
Vapour Pressure: 0.0635 mmHg at 25°C
Structure Descriptors of Antiradon (CAS NO.56-10-0):
InChI : InChI=1/C3H9N3S.2BrH/c4-1-2-7-3(5)6;;/h1-2,4H2,(H3,5,6);2*1H
Smiles: S(C(N)=N)CCN.Br.Br
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intraperitoneal | 113mg/kg (113mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 142, Pg. 510, 1963. |
dog | LD50 | oral | 177mg/kg (177mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 142, Pg. 510, 1963. |
guinea pig | LD50 | intraperitoneal | 356mg/kg (356mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 218, 1960. |
mouse | LD50 | intraperitoneal | 400mg/kg (400mg/kg) | National Technical Information Service. Vol. AD277-689, | |
mouse | LD50 | intravenous | 85400ug/kg (85.4mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 218, 1960. |
mouse | LD50 | oral | 815mg/kg (815mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 218, 1960. |
mouse | LD50 | subcutaneous | 242mg/kg (242mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 576, 1957. | |
rabbit | LD50 | intraperitoneal | 236mg/kg (236mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 142, Pg. 510, 1963. |
rat | LD50 | intraperitoneal | 288mg/kg (288mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 142, Pg. 198, 1963. | |
rat | LD50 | intravenous | 85mg/kg (85mg/kg) | Casopis Lekaru Ceskych. Journal of Czech Physicians. Vol. 105, Pg. 1165, 1966. |
Safety Information of Antiradon (CAS NO.56-10-0):
Hazard Codes: Xn
Risk Statements: 22-36/37/38
22: Harmful if swallowed
36: Irritating to the eyes
37: Irritating to the respiratory system
38: Irritating to the skin
Safety Statements: 26-36/37-22
22: Do not breathe dust
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing
37: Wear suitable gloves
Antiradon ,its CAS NO. is 56-10-0,the synonyms is 2-(2-Aminoethyl)-2-thiopseudourea dihydrobromide ; 2-(2-Aminoethyl)-2-thiopseudourea hydrobromide ; 2-(beta-Aminoethyl)isothiouronium bromide hydrobromide ; 2-Aminoethylisothiouronium dibromide ; 2-Aminoethylisothiuronium bromide hydrobromide ; 2-Aminoethylisothiuronium dihydrobromide ; 2-Aminoethylthiopseudourea dihydrobromide ; 2beta-Aminoethylisothiourea-bromide-hydrogen bromide ; Aminoethylisothiuronium bromide hydrobromide ; Carbamimidothioic acid, 2-aminoethyl ester, dihydrobromide ; EINECS 200-257-0 ; Isothiuronium bromide, aminoethyl-, hydrobromide ; Ixecur ; NSC 22877 ; Pseudourea, (2-aminoethyl)-2-thio-, dihydrobromide ; S-(2-Aminoaethyl)isothiuronium dibromid ; S-(2-Aminoethyl)isothiuronium dibromide ; S-(2-Aminoethyl)pseudothiourea dihydrobromide ; S-2-Aminoethylisothiouronium bromide hydrobromide ; S-Aminoethylisothiuronium bromide hydrobromide ; S-beta-Aminoethylisothiuronium bromohydrate ; Surrectan ; USAF XR-31 ; beta-Aminoaethyl-isothiuronium dihydrobromid ; beta-Aminoethylisothiouronium bromide hydrobromide ; Carbamimidothioic acid, 2-aminoethyl ester, dihydrobromide ; Carbamimidothioic acid, 2-aminoethyl ester, hydrobromide (1:2) .